Q2 2021 13F Holders as of 6/30/2021
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
66.6M
-
Number of holders
-
296
-
Total 13F shares, excl. options
-
59M
-
Shares change
-
+2M
-
Total reported value, excl. options
-
$5.75B
-
Value change
-
+$205M
-
Put/Call ratio
-
0.44
-
Number of buys
-
157
-
Number of sells
-
-130
-
Price
-
$97.40
Significant Holders of TANDEM DIABETES CARE INC - Common Stock, par value $0.001 per share (TNDM) as of Q2 2021
356 filings reported holding TNDM - TANDEM DIABETES CARE INC - Common Stock, par value $0.001 per share as of Q2 2021.
TANDEM DIABETES CARE INC - Common Stock, par value $0.001 per share (TNDM) has 296 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 59M shares
of 66.6M outstanding shares and own 88.68% of the company stock.
Largest 10 shareholders include FMR LLC (5.99M shares), VANGUARD GROUP INC (5.6M shares), Jackson Square Partners, LLC (3.62M shares), BlackRock Inc. (3.52M shares), Capital World Investors (3.28M shares), CREDIT SUISSE AG/ (1.68M shares), Invesco Ltd. (1.6M shares), Champlain Investment Partners, LLC (1.55M shares), FEDERATED HERMES, INC. (1.27M shares), and BROWN CAPITAL MANAGEMENT LLC (1.23M shares).
This table shows the top 296 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.